Chemically named N-methylnicotinate inner salt, trigonelline was first isolated from fenugreek seeds, from which it derives its common name. It is not exclusive to fenugreek; it is also found in coffee beans, alfalfa, marine algae, as well as traditional Chinese medicinal herbs such as astragalus and licorice. Fenugreek seeds remain its classic source. In traditional herbal practice, fenugreek has long been applied for glucose regulation and anti-inflammatory purposes. Roasted coffee beans contain relatively high levels of trigonelline, which contributes to coffee flavour and constitutes an important material basis for coffee’s health-related effects.

Modern scientific research continues to uncover the health-related potential of trigonelline. Multiple studies have confirmed its diverse biological activities. For glycaemic-metabolism management, trigonelline improves insulin sensitivity, boosts glucose utilization in the body and assists in blood-glucose modulation. This provides the material foundation for fenugreek as a traditional hypoglycaemic herb.

Meanwhile, trigonelline possesses prominent antioxidant and anti-inflammatory capacity. It scavenges endogenous free radicals, alleviates oxidative-stress damage and inhibits the release of inflammatory mediators, delivering supportive benefits for conditions linked to chronic inflammation. In the field of neural health, trigonelline can cross the blood-brain barrier. Animal studies have demonstrated its neuroprotective and cognition-enhancing properties, indicating potential research value for neurodegenerative disorders such as Alzheimer’s disease. Furthermore, relevant research suggests that trigonelline helps modulate blood-lipid profiles, reduce atherosclerosis risk and maintain cardiovascular homeostasis. In-vitro experiments have also observed its moderate bacteriostatic potential and ability to induce tumour-cell apoptosis. Nevertheless, anti-tumour applications await further validation from clinical trials.

With deepening basic research, the industrial application landscape of trigonelline keeps expanding. At present, it covers four major sectors: health foods, pharmaceutical research, cosmetics and agriculture. Within health-food applications, it can be formulated into functional beverages and dietary supplements. In pharmacy, it is regarded as a candidate molecule for anti-diabetes and neurodegenerative-disease drug development. The cosmetics industry leverages its antioxidant and anti-ageing properties for skincare formulations. In agriculture, it can be utilized as a plant-growth regulator and natural bactericide.

Numerous domestic and international research institutions are advancing studies on trigonelline, focusing on metabolic diseases, neurodegenerative disorders and anti-tumour research. Continuous iteration of synthetic modification, extraction and purification technologies further lowers barriers for large-scale manufacturing.

Industry insiders state that as a plant-sourced natural active molecule, trigonelline bridges traditional herbal experience and modern scientific research. Objectively, however, most claimed benefits are still supported only by in-vitro and animal studies, while large-scale human clinical data remain limited. During commercial development, it is essential to rationally recognize efficacy boundaries and strictly comply with regulatory standards. Going forward, with accumulating clinical evidence and optimized production processes, trigonelline is expected to achieve greater breakthroughs across food, pharmaceutical, cosmetic and other industries.

Disclaimer: This article shares industry-related scientific information only. It does not constitute product-efficacy promotion or medical advice.